Stonepine Capital Management, LLC - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 126 filers reported holding ANI PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 2.71 and the average weighting 0.2%.

Quarter-by-quarter ownership
Stonepine Capital Management, LLC ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$854,000
+16.5%
28,800
+10.5%
0.40%
+30.6%
Q1 2022$733,000
-69.6%
26,060
-50.2%
0.30%
-72.5%
Q4 2021$2,410,000
+4203.6%
52,290
+3069.1%
1.11%
+1575.8%
Q1 2016$56,0001,6500.07%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
FIRST WILSHIRE SECURITIES MANAGEMENT INC 367,754$10,911,0004.08%
AIGH Capital Management LLC 244,500$7,254,0001.91%
Parkman Healthcare Partners LLC 108,559$3,221,0001.19%
Worth Venture Partners, LLC 60,831$1,927,0001.13%
Global Alpha Capital Management Ltd. 323,731$9,605,0001.04%
Mesirow Financial Investment Management, Inc. 6,892$204,0000.99%
MARATHON CAPITAL MANAGEMENT 74,460$2,209,0000.71%
EMERALD ADVISERS, LLC 455,880$13,526,0000.70%
EMERALD MUTUAL FUND ADVISERS TRUST 356,865$10,588,0000.61%
Jackson Creek Investment Advisors LLC 32,698$1,120,0000.45%
View complete list of ANI PHARMACEUTICALS INC shareholders